S-22-01 Human biomonitoring of exposure to legacy and replacement endocrine disrupting chemicals. (1st September 2022) - Schoeters, G.; Govarts, E.; Gilles, L.; Sepai, O.; Castano, A.; Lopez, M. Esteban; Kolossa-Gehring, M.